When reviewing a Certificate of Analysis (COA) for a research peptide, you may encounter results from HPLC and mass spectrometry (MS). Although these analytical methods are often reported together, they do not provide exactly the same information.
In simple terms, HPLC is commonly used to evaluate purity and the separation of components within a sample, while mass spectrometry can provide information about molecular mass and identity. Used together, these methods can provide a much more complete analytical picture of a research peptide.
Understanding the difference is important when evaluating laboratory documentation and determining what a COA actually tells you about a research material.
What Is HPLC?
High-Performance Liquid Chromatography (HPLC) is an analytical technique used to separate the different components present in a sample.
A dissolved sample is introduced into the HPLC system and carried through a specialized column. Different components interact with the column differently and therefore move through it at different rates.
As those components leave the column, a detector records the resulting signals.
The result is a chromatogram containing a series of peaks.
The primary peptide will typically produce a dominant peak, while smaller peaks may represent other detectable components or peptide-related impurities.
This makes HPLC particularly useful for evaluating the relative purity of a peptide sample.
What Does an HPLC Purity Result Mean?
A laboratory may report an HPLC purity result such as:
Purity: 99.2%
This generally indicates that the main detected chromatographic component represented approximately 99.2% of the integrated signal under the specific analytical conditions used.
However, an important distinction needs to be made.
HPLC purity is not necessarily the same as the total amount of peptide contained in a vial.
For example, a sample can produce a very high chromatographic purity result while the actual quantity of peptide present may still need to be determined using a separate quantitative analytical method.
This distinction between purity, identity, and quantity is one of the most important concepts when interpreting peptide laboratory results.
What Is Mass Spectrometry?
Mass spectrometry (MS) analyzes molecules according to their mass-to-charge ratio.
The sample is converted into charged particles called ions. The mass spectrometer then measures those ions with extremely high precision.
For peptide analysis, the experimentally measured molecular mass can be compared with the expected molecular mass of the target peptide.
When the measured value closely corresponds with the expected value, it provides evidence supporting the identity of the material being analyzed.
More advanced mass-spectrometry techniques can provide additional structural information and may help characterize peptide sequences and peptide-related impurities.
Purity and Identity Are Not the Same Thing
This is where HPLC and mass spectrometry complement one another.
Imagine that a laboratory analyzes a research peptide and obtains:
HPLC purity: 99.4%
That tells us that one component dominates the chromatographic analysis.
But an obvious question remains:
Is that dominant component actually the peptide it is supposed to be?
This is where mass spectrometry becomes valuable.
If the molecular mass measured by MS corresponds with the expected molecular mass of the target peptide, the laboratory has another analytical measurement supporting the material’s identity.
Put simply:
HPLC helps answer: “How pure is the sample?”
Mass spectrometry helps answer: “Does the analyzed material have the expected molecular mass?”
Neither question should automatically be substituted for the other.
Why Laboratories May Use Both Methods
Modern analytical laboratories frequently combine chromatography and mass spectrometry because the techniques provide complementary information.
The U.S. Food and Drug Administration has discussed the use of high-resolution liquid chromatography–mass spectrometry methods for detecting and characterizing peptide-related impurities. Research involving FDA scientists has also demonstrated that LC-HRMS methods can provide information about peptide impurities, composition and sequence.
Using complementary analytical techniques can therefore provide substantially more information than relying on a single measurement.
For research materials, this can help establish a clearer analytical picture of:
- chromatographic purity
- molecular identity
- potential peptide-related impurities
- consistency between samples or batches
- whether observed analytical results correspond with expected characteristics
What Is LC-MS?
You may also encounter the abbreviation LC-MS on laboratory reports.
LC-MS stands for Liquid Chromatography–Mass Spectrometry.
Rather than treating chromatography and mass spectrometry as completely separate procedures, LC-MS combines the two technologies.
Liquid chromatography first separates the components of the sample. Those separated components can then enter the mass spectrometer for further analysis.
This combination is particularly powerful because researchers can obtain information about both separation characteristics and molecular mass within the same analytical workflow.
More sophisticated versions, such as LC-HRMS (Liquid Chromatography–High Resolution Mass Spectrometry), can provide even more detailed characterization.
What Should You Look for on a Peptide COA?
When reviewing a peptide Certificate of Analysis, do not focus exclusively on a large purity percentage printed at the top of the document.
Look at the analytical information supporting that number.
Depending on the testing performed, useful documentation may include:
- the reported HPLC purity
- an HPLC chromatogram
- mass spectrometry results
- expected and observed molecular mass
- sample or batch identification
- testing date
- laboratory identification
- analytical methodology
- supporting chromatograms or spectra
A COA becomes considerably more informative when the reported results can be connected to actual analytical data.
Researchers should also remember that no single number describes every aspect of sample quality.
Why Independent Laboratory Testing Matters
The laboratory performing the analysis is another important consideration.
Independent third-party testing provides analytical information from a laboratory separate from the supplier or manufacturer.
This does not mean that every third-party COA is automatically reliable. The documentation still needs to be reviewed carefully.
Researchers should consider whether the report clearly identifies the sample, the analytical methods used, the results obtained and the laboratory responsible for the testing.
This is why Recherche Logistique emphasizes batch-specific analytical documentation rather than relying solely on generic purity claims.
Understanding the Bigger Picture
HPLC and mass spectrometry answer different analytical questions.
HPLC provides important information about the components separated within a sample and is commonly used to determine chromatographic purity.
Mass spectrometry provides information about molecular mass and can support confirmation of peptide identity.
When these methods are used together, researchers gain a more complete understanding of the material being evaluated.
The key point is simple:
Purity does not automatically establish identity, and identity alone does not establish purity.
Understanding that distinction makes it much easier to interpret peptide COAs and laboratory results correctly.
Continue Learning
For more information about evaluating research peptide documentation, explore these resources from the Recherche Logistique Research Knowledge Center:
- What Is Peptide Purity? Understanding Purity, Identity, and Quality in Research Peptides
- How to Verify a Peptide Certificate of Analysis (COA) in Canada
- Why Third-Party Laboratory Testing Matters for Research Materials
- Understanding Independent Laboratory Testing and Certificates of Analysis (COAs)
This article is provided for educational and research-information purposes. Recherche Logistique products are intended for laboratory research use only and are not for human consumption.
